Skip to main content
SpringerLink
Log in

Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines

  • Original Article
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Medulloblastoma (MB) is the most common malignant brain tumor in children. Recent advances in molecular technologies allowed to classify MB in 4 major molecular subgroups: WNT, SHH, Group 3 and Group 4. In cancer research, cancer cell lines are important for examining and manipulating molecular and cellular process. However, it is important to know the characteristics of each cancer cell line prior to use, because there are some differences among them, even if they originate from the same cancer type. This study aimed to evaluate the similarities and differences among four human medulloblastoma cell lines, UW402, UW473, DAOY and ONS-76. The medulloblastoma cell lines were analyzed for (1) cell morphology, (2) immunophenotyping by flow cytometry for some specifics surface proteins, (3) expression level of adhesion molecules by RT-qPCR, (4) proliferative potential, (5) cell migration, and (6) in vivo tumorigenic potential. It was observed a relationship between cell growth and CDH1 (E-chaderin) adhesion molecule expression and all MB cell lines showed higher levels of CDH2 (N-chaderin) when compared to other adhesion molecule. ONS-76 showed higher gene expression of CDH5 (VE-chaderin) and higher percentage of CD144/VE-chaderin positive cells when compared to other MB cell lines. All MB cell lines showed low percentage of CD34, CD45, CD31, CD133 positive cells and high percentage of CD44, CD105, CD106 and CD29 positive cells. The DAOY cell line showed the highest migration potential, the ONS-76 cell line showed the highest proliferative potential and only DAOY and ONS-76 cell lines showed tumorigenic potential in vivo. MB cell lines showed functional and molecular differences among them, which it should be considered by the researchers in choosing the most suitable cellular model according to the study proposal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Aragon-Sanabria V, Pohler SE, Eswar VJ et al (2017) VE-cadherin disassembly and cell contractility in the endothelium are necessary for barrier disruption induced by tumor cells. Sci Rep 7:45835

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arcinas Arthur, Ten-Yang Yen EK, Macher Bruce A (2010) Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns. J Proteome Res 8:3958–3968

    Article  Google Scholar 

  • Asuthkar S, Guda MR, Martin SE et al (2016) Hand1 overexpression inhibits medulloblastoma metastasis. Biochem Biophys Res Commun 477:215–221

    Article  CAS  PubMed  Google Scholar 

  • Barrallo-Gimeno A (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151–3161

    Article  CAS  PubMed  Google Scholar 

  • Blazek ER, Foutch JL, Maki G (2007) Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133− cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 67:1–5

    Article  CAS  PubMed  Google Scholar 

  • Calaora V, Chazal G, Nielsen PJ et al (1996) mCD24 expression in the developing mouse brain and in zones of secondary neurogenesis in the adult. Neuroscience 73:581–594

    Article  CAS  PubMed  Google Scholar 

  • Cao X, Geradts J, Dewhirst MW, Lo HW (2012) Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 31:104–115

    Article  CAS  PubMed  Google Scholar 

  • Cavalli FMG, Remke M, Rampasek L et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737–754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chou YY, Jeng YM, Lee TT et al (2007) Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Ann Surg Oncol 14:2748–2758

    Article  PubMed  Google Scholar 

  • Cruzeiro GAV, Salomão KB, de Biagi CAO et al (2019) A simplified approach using Taqman low-density array for medulloblastoma subgrouping. Acta Neuropathol Commun 7:33. https://doi.org/10.1186/s40478-019-0681-y

    Article  PubMed  PubMed Central  Google Scholar 

  • Du J, Wu Y, Liu Y et al (2014) E-cadherin is critical for SC1-induced colony growth of F9 embryonic carcinoma cells. Cell Physiol Biochem 33:501–512

    Article  CAS  PubMed  Google Scholar 

  • Eberhart CG, Kepner JL, Goldthwaite PT et al (2002) Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 94:552–560

    Article  PubMed  Google Scholar 

  • Fonsatti E, Nicolay HJM, Altomonte M et al (2010) Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res 86:12–19. https://doi.org/10.1093/cvr/cvp332

    Article  CAS  PubMed  Google Scholar 

  • Gedye CA, Hussain A, Paterson J et al (2014) Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity. PLoS ONE 9:e105602

    Article  PubMed  PubMed Central  Google Scholar 

  • Geng S, Guo Y, Wang Q et al (2013) Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial–mesenchymal transition in squamous cell carcinoma. Arch Dermatol Res 305:35–47. https://doi.org/10.1007/s00403-012-1260-2

    Article  CAS  PubMed  Google Scholar 

  • Grunder E, D’Ambrosio R, Fiaschetti G et al (2011) MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer 47:2479–2490

    Article  CAS  PubMed  Google Scholar 

  • Hawkins K, Mohamet L, Ritson S et al (2012) E-cadherin and in its absence, N-cadherin promotes nanog expression in mouse embryonic stem cells via STAT3 Phosphorylation. Stem Cells 30:1842–1851

    Article  CAS  PubMed  Google Scholar 

  • He R, Zhang F, Shen N (2017) LncRNA FEZF1-AS1 enhances epithelial–mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). Biomed Pharmacother 95:331–338

    Article  CAS  PubMed  Google Scholar 

  • Hendrix MJC, Seftor EA, Meltzer PS et al (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci 98:8018–8023. https://doi.org/10.1073/pnas.131209798

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ivanov DP, Coyle B, Walker DA, Grabowska AM (2016) In vitro models of medulloblastoma: choosing the right tool for the job. J Biotechnol 236:10–25

    Article  CAS  PubMed  Google Scholar 

  • Jones DT, Jager N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100–105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanatsu-Shinohara M, Takehashi M, Takashima S et al (2008) Homing of mouse spermatogonial stem cells to germline niche depends on β1-integrin. Cell Stem Cell 3:533–542

    Article  CAS  PubMed  Google Scholar 

  • Krause DS, Mucenski ML, Lawler AM, May WS (1998) CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb. Exp Hematol 26:1086–1092

    CAS  PubMed  Google Scholar 

  • Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG (2016) Multiple roles of CD90 in cancer. Tumor Biol 37:11611–11622

    Article  CAS  Google Scholar 

  • Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial–mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li K, He W, Lin N et al (2009) N-cadherin knock-down decreases invasiveness of esophageal squamous cell carcinoma in vitro. World J Gastroenterol 15:697–704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liang L, Aiken C, McClelland R et al (2015) Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes. Oncotarget 6:38881–38900

    PubMed  PubMed Central  Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4

    Article  PubMed  PubMed Central  Google Scholar 

  • Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 57:301–311

    Google Scholar 

  • McManamy CS, Pears J, Weston CL et al (2007) Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17:151–164. https://doi.org/10.1111/j.1750-3639.2007.00058.x

    Article  PubMed  PubMed Central  Google Scholar 

  • Northcott PA, Shih DJH, Peacock J et al (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488:49–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ouhtit A, Abdraboh ME, Hollenbach AD et al (2017) CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion. Cell Commun Signal 15:45

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pantazi E, Gemenetzidis E, Teh MT et al (2017) GLI2 is a regulator of β-catenin and is associated with loss of E-cadherin, cell invasiveness, and long-term epidermal regeneration. J Invest Dermatol 137:1719–1730

    Article  CAS  PubMed  Google Scholar 

  • Pui C-H, Gajjar AJ, Kane JR et al (2011) Challenging issues in pediatric oncology. Nat Rev Clin Oncol 8:540–549

    Article  PubMed  PubMed Central  Google Scholar 

  • Raso A, Negri F, Gregorio A et al (2008) Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma. Neuropathol Appl Neurobiol 34:306–315

    Article  CAS  PubMed  Google Scholar 

  • Read TA, Fogarty MP, Markant SL et al (2009) Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 15:135–147

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ricardo S, Vieira AF, Gerhard R et al (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64:937–946

    Article  PubMed  Google Scholar 

  • Robinson G, Parker M, Kranenburg TA et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43–48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rochefort P, Chabaud S, Pierga J-Y et al (2017) Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival. Br J Cancer 116:356–361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rutkowski S, von Hoff K, Emser A et al (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28:4961–4968

    Article  PubMed  Google Scholar 

  • Sandén E, Dyberg C, Krona C et al (2015) Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. J Neurooncol. https://doi.org/10.1007/s11060-015-1758-5

    Article  PubMed  Google Scholar 

  • Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29. https://doi.org/10.3322/caac.20138.Available

    Article  PubMed  Google Scholar 

  • Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828. https://doi.org/10.1038/nature03128

    Article  CAS  PubMed  Google Scholar 

  • Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401. https://doi.org/10.1038/nature03128

    Article  CAS  PubMed  Google Scholar 

  • Skowron P, Ramaswamy V, Taylor MD (2015) Genetic and molecular alterations across medulloblastoma subgroups. J Mol Med 93:1075–1084

    Article  CAS  PubMed  Google Scholar 

  • Sneha S, Nagare RP, Priya SK et al (2017) Therapeutic antibodies against cancer stem cells: a promising approach. Cancer Immunol Immunother 233:706–720

    Google Scholar 

  • Sun L, Moritake T, Zheng YW et al (2013) In vitro stemness characterization of radio-resistant clones isolated from a medulloblastoma cell line ONS-76. J Radiat Res 54:61–69

    Article  CAS  PubMed  Google Scholar 

  • Ullmann U, In’t Veld P, Gilles C et al (2007) Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 13:21–32

    Article  CAS  PubMed  Google Scholar 

  • Woodfin A, Voisin MB, Nourshargh S (2007) PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 27:2514–2523

    Article  CAS  PubMed  Google Scholar 

  • Woodford-Thomas T, Thomas ML (1993) The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoietic cells. Semin Cell Dev Biol 4:409–418

    Article  CAS  Google Scholar 

  • Zanini C, Ercole E, Mandili G et al (2013) Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications. PLoS ONE 8:e63748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang K, Che S, Su Z et al (2018) CD90 promotes cell migration, viability and sphere-forming ability of hepatocellular carcinoma cells. Int J Mol Med 41:946–954

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Process Numbers: 2011/18664-7 and 2011/20829-4 for the financial support for this study.

Author information

Authors and Affiliations

  1. Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900 Monte Alegre, Ribeirão Preto, São Paulo, ZIP code: 14049-900, Brazil

    Ricardo Bonfim-Silva, Karina Bezerra Salomão & Aparecida Maria Fontes

  2. Department of Medical Clinic, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900 Monte Alegre, Ribeirão Preto, São Paulo, ZIP code: 14049-900, Brazil

    Thais Valéria Costa de Andrade Pimentel

  3. Ribeirão Preto Blood Center, Clinics Hospital of the Ribeirão Preto Medical School, University of São Paulo, Av. Tenente Catão Roxo, 2501 Monte Alegre, Ribeirão Preto, São Paulo, ZIP code: 14051-140, Brazil

    Camila Cristina Branquinho de Oliveira Menezes & Patrícia Vianna Bonini Palma

Authors
  1. Ricardo Bonfim-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karina Bezerra Salomão
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thais Valéria Costa de Andrade Pimentel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Camila Cristina Branquinho de Oliveira Menezes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrícia Vianna Bonini Palma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aparecida Maria Fontes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo Bonfim-Silva.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

All the animal procedures of this study were done in agreement with the ETHICAL PRINCIPLES IN ANIMAL RESEARCH adopted by the Brazilian College of Animal Experimentation (COBEA) and this study was approved by the Ethics Committee on Animal Experiments of the Ribeirão Preto Medical School under Protocol Number 137/2011.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonfim-Silva, R., Salomão, K.B., Pimentel, T.V.C.d. et al. Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines. Cytotechnology 71, 893–903 (2019). https://doi.org/10.1007/s10616-019-00332-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-019-00332-3

Keywords

Search

Navigation